Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Scholar Rock Holding CorporationNASDAQ: SRRK
Investing Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Investing cash flow dips below year-ago levels
Q3 FY2026 investing cash flow of $7.94M fell 86.7% year over year, behind the +330.5% change in trailing-twelve-month investing cash flow.
Context
- Investing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -86.7% toward the trailing-twelve-month pace of +330.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 218.69M USD
- Year-over-year change
- +387.5%
- 4-year CAGR
- +13.0%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 218.69M | +387.5% |
| FY2024 | 2024-12-31 | (76.06M) | -284.9% |
| FY2023 | 2023-12-31 | 41.14M | +124.0% |
| FY2022 | 2022-12-31 | (171.7M) | -227.8% |
| FY2021 | 2021-12-31 | 134.32M | — |
Investing Cash Flow vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 investing cash flow of $36.08M is the 10th largest of the 11 companies compared; the peer median is $39.15M.
- Its year-over-year change of +330.5% is the 3rd highest of 11, against a peer median of +34.0%.
- Investing cash flow amounts to 6329.3% of revenue for SRRK, versus a peer median of 46.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $622.63M | -345.3% | — | — | |
| LTM Jun 2026 | $471.91M | +23.8% | — | 46.8% | |
| LTM Sep 2026 | $240.69M | +14.6% | +1.9% | 25.1% | |
| LTM Mar 2026 | $226.43M | -7.8% | — | 10.4% | |
| LTM Sep 2026 | $190.36M | +408.9% | -22.5% | — | |
| LTM Jun 2026 | $189.46M | +231.1% | -35.9% | 121.4% | |
| LTM Mar 2026 | $164.39M | +13986.4% | +277.8% | 821.9% | |
| LTM Mar 2026 | $149.75M | +44.2% | +59.7% | 466.8% | |
| LTM Jun 2026 | $44.17M | +62.5% | — | — | |
| LTM Sep 2026 | $36.08M | +330.5% | — | 6329.3% | |
| LTM Jun 2026 | $34.14M | -267.4% | — | 4.8% | |
| Peer median (excluding SRRK) | $39.15M | +34.0% | +1.9% | 46.8% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 23.15M | 27.7M | 27.14M | 36.63M | 75.6M |
| Change in Working Capital | (28.44M) | (34.39M) | (10.61M) | 6.59M | (1.05M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.02M | (251K) | (529K) | 6.63M | 208K |
| Other Working Capital | (29.46M) | (34.14M) | (10.09M) | (36K) | (1.26M) |
| Other Non-Cash Items | 7.67M | 5.51M | 1.19M | 186K | 1.7M |
| Operating Cash Flow | (126.79M) | (132.69M) | (145.23M) | (200.95M) | (300.04M) |
| Capital Expenditures | (5.25M) | (1.06M) | (71K) | (98K) | (602K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (60.44M) | (300.63M) | (290.8M) | (293.16M) | (98.01M) |
| Sales of Investments | 200M | 130M | 332M | 217.2M | 317.3M |
| Other Investing Activities | 0 | 0 | 13K | 0 | 0 |
| Investing Cash Flow | 134.32M | (171.7M) | 41.14M | (76.06M) | 218.69M |
| Debt Repayment | 24.98M | (975K) | 0 | 0 | 49.14M |
| Common Stock Issued | 13.1M | 195.32M | 97.71M | 324.41M | 179.26M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 6.87M | 492K | 4.87M | 28.61M | 0 |
| Financing Cash Flow | 44.95M | 194.83M | 102.57M | 353.03M | 228.4M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (2K) |
| Net Change in Cash | 52.48M | (109.56M) | (1.51M) | 76.02M | 147.05M |
| Free Cash Flow | (132.04M) | (133.76M) | (145.3M) | (201.05M) | (300.64M) |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.